Enhancer RNA promotes resistance to radiotherapy in bone-metastatic prostate cancer by m(6)A modification

Rationale: Prostate cancer metastasizes to the bone with the highest frequency and exhibits high resistance to (177)Lu-prostate-specific membrane antigen (PSMA) radioligand therapy. Little is known about bone metastatic prostate cancer (mPCa) resistance to radiation. Methods: We filtered the metasta...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yu, Wen, Simeng, Li, Hang, Pan, Chun-Wu, Wei, Yulei, Huang, Ting, Li, Zhaochen, Yang, Yinhui, Fan, Saijun, Zhang, Yingyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830431/
https://www.ncbi.nlm.nih.gov/pubmed/36632223
http://dx.doi.org/10.7150/thno.78687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830431/
https://www.ncbi.nlm.nih.gov/pubmed/36632223
http://dx.doi.org/10.7150/thno.78687

Ejemplares similares